Physician profile
Patrick Risch
NPI 1003104498
$1,894.23
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $226 · 2021: $111 · 2022: $231 · 2023: $174 · 2024: $475 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.79 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $485.80 | 2019-2022 | |
| Rxsight INC | $379.36 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Bausch & Lomb Americas INC. | $246.18 | 2023-2024 | Envista Mx60 Iol, Envista Envy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.82 | 2019 | |
| Biotissue Holdings INC. | $149.37 | 2022-2025 | |
| The Cameron-Ehlen Group, INC. | $116.77 | 2020 | |
| Aerie Pharmaceuticals, INC. | $105.35 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $60.02 | 2021-2023 | Tecnis Iol |
| Allergan, INC. | $54.36 | 2020 | |
| Alcon Vision LLC | $35.70 | 2019-2021 | |
| Abbvie INC. | $28.20 | 2023 | Lumigan, Alphagan P |
| Optos, INC. | $20.43 | 2019 | |
| Harrow Eye, LLC | $18.98 | 2025 | Triesence |
| Novartis Pharmaceuticals Corporation | $16.85 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $14.57 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Risch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.